Literature DB >> 30100260

Factors and outcomes associated with candidemia caused by non-albicans Candida spp versus Candida albicans in children.

Wei-Ju Lee1, Jen-Fu Hsu2, Mei-Yin Lai2, Ming-Chou Chiang2, Han-Chen Lin3, Hsuan-Rong Huang2, I-Hsyuan Wu2, Shih-Ming Chu2, Ren-Huei Fu2, Ming-Horng Tsai4.   

Abstract

BACKGROUND: Candidemia in children caused by non-albicans Candida (NAC) spp is increasing in prevalence, but the relevant information is limited.
METHODS: All isolates of pediatric candidemia from a medical center in Taiwan between 2003 and 2015 were enrolled. The characteristics of patients with NAC and Candida albicans candidemia (CAC) were compared.
RESULTS: Among the 319 episodes of candidemia occurring in 262 patients, C albicans accounted for 46.4%. The NAC and CAC groups had no significant differences in demographics, underlying diseases, most risk factors, and clinical characteristics. Patients in the NAC group were significantly more likely to have fluconazole exposure (14.0% vs 6.8%, respectively; P = .045), and NAC species accounted for 70.2% of all recurrent episodes. NAC candidemia had a longer duration of candidemia (median, 3.0 vs 1.0 days after effective antifungal treatment, respectively; P = .001), slower responses to antifungal treatment, and a higher rate of treatment failure than CAC. However, the 2 groups had similar 30-day candidemia-attributable mortality rates. After multivariate logistic regression, longer duration of central venous catheter was the independent risk factor for NAC candidemia in children (odds ratio, 1.21; 95% confidence interval, 1.08-1.35 for every 10-day increment).
CONCLUSIONS: NAC species collectively have emerged as the predominant pathogens of candidemia in children. Prolonged use of a central venous catheter is associated with an increased risk of candidemia caused by NAC species.
Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bloodstream infection; antifungal susceptibility; candidemia; invasive candidiasis; mortality

Mesh:

Substances:

Year:  2018        PMID: 30100260     DOI: 10.1016/j.ajic.2018.05.015

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

1.  Clinical and Microbiological Characteristics of Neonates with Candidemia and Impacts of Therapeutic Strategies on the Outcomes.

Authors:  Yu-Ning Chen; Jen-Fu Hsu; Shih-Ming Chu; Mei-Yin Lai; Chih Lin; Hsuan-Rong Huang; Peng-Hong Yang; Ming-Chou Chiang; Ming-Horng Tsai
Journal:  J Fungi (Basel)       Date:  2022-04-29

2.  Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells.

Authors:  Jhones do Nascimento Dias; Calliandra de Souza Silva; Alyne Rodrigues de Araújo; Jessica Maria Teles Souza; Paulo Henrique de Holanda Veloso Júnior; Wanessa Felix Cabral; Maria da Glória da Silva; Peter Eaton; José Roberto de Souza de Almeida Leite; André Moraes Nicola; Patrícia Albuquerque; Ildinete Silva-Pereira
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

3.  First Genome Sequences of Two Multidrug-Resistant Candida haemulonii var. vulnera Isolates From Pediatric Patients With Candidemia.

Authors:  Luiza Souza Rodrigues; Rajesh Kumar Gazara; Hemanoel Passarelli-Araujo; Andressa Eloisa Valengo; Paula Veronesi Marinho Pontes; Rodrigo Nunes-da-Fonseca; Robson Francisco de Souza; Thiago Motta Venancio; Libera Maria Dalla-Costa
Journal:  Front Microbiol       Date:  2020-07-03       Impact factor: 5.640

4.  Characteristics of Extracellular Vesicles Released by the Pathogenic Yeast-Like Fungi Candida glabrata, Candida parapsilosis and Candida tropicalis.

Authors:  Justyna Karkowska-Kuleta; Kamila Kulig; Elzbieta Karnas; Ewa Zuba-Surma; Olga Woznicka; Elzbieta Pyza; Patryk Kuleta; Artur Osyczka; Maria Rapala-Kozik; Andrzej Kozik
Journal:  Cells       Date:  2020-07-18       Impact factor: 6.600

5.  Candidemia in Children with Malignancies: Report from the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology.

Authors:  Eleni Vasileiou; Anna Paisiou; Charoula Tsipou; Apostolos Pourtsidis; Vasiliki Galani; Nikolaos Katzilakis; Kondilia Antoniadi; Eugenia Papakonstantinou; Elda Ioannidou; Efthichia Stiakaki; Margarita Baka; Antonios Kattamis; Vasiliki Kitra; Athanasios Tragiannidis
Journal:  J Fungi (Basel)       Date:  2020-11-10

Review 6.  Mechanisms of Pathogenic Candida Species to Evade the Host Complement Attack.

Authors:  Dhirendra Kumar Singh; Renáta Tóth; Attila Gácser
Journal:  Front Cell Infect Microbiol       Date:  2020-03-12       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.